Iq Eq Fund Management (Ireland) LTD Beam Therapeutics Inc. Transaction History
Iq Eq Fund Management (Ireland) LTD
- $831 Million
- Q4 2024
A detailed history of Iq Eq Fund Management (Ireland) LTD transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Iq Eq Fund Management (Ireland) LTD holds 32,198 shares of BEAM stock, worth $979,785. This represents 0.1% of its overall portfolio holdings.
Number of Shares
32,198
Previous 13,118
145.45%
Holding current value
$979,785
Previous $321,000
148.6%
% of portfolio
0.1%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding BEAM
# of Institutions
253Shares Held
78.6MCall Options Held
304KPut Options Held
142K-
Farallon Capital Management LLC San Francisco, CA8.24MShares$251 Million1.09% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$232 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.62MShares$232 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.07MShares$215 Million1.53% of portfolio
-
Arch Venture Management, LLC Chicago, IL4.54MShares$138 Million70.85% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $2.14B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...